SCHEMBL24140397

SCHEMBL24140397

CCOC(=O)c1csc([C@@H](C[C@@H](N)C(C)C)O[Si](C)(C)C(C)(C)C)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.48
RAB9A P51151 10/20 0.44
NPC1 O15118 8/20 0.44
MAPT P10636 5/20 0.44
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
PTPRB P23467 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
HSP90AA1 P07900 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
GAA P10253 3/20 0.38
POLB P06746 2/20 0.37
PKM P14618 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
CA2 P00918 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28634475 0.89 ABCB1 (0.38) ABCB1RAB9ANPC1MAPTALDH1A1
SCHEMBL28634476 0.89 ABCB1 (0.38) ABCB1RAB9ANPC1MAPTALDH1A1
SCHEMBL24140420 0.82 ABCB1 (0.62) ABCB1RAB9ANPC1MAPTALDH1A1
SCHEMBL30360077 0.81 ABCB1 (0.44) ABCB1RAB9ANPC1MAPTALDH1A1
SCHEMBL10042788 0.80 RAB9A (0.52) ABCB1RAB9ANPC1MAPTALDH1A1
SCHEMBL28629445 0.80 ABCB1 (0.43) ABCB1RAB9ANPC1MAPTALDH1A1
SCHEMBL28629446 0.80 ABCB1 (0.43) ABCB1RAB9ANPC1MAPTALDH1A1
Hydrochloric Acid SCHEMBL20529546 0.79 RAB9A (0.54) ABCB1RAB9ANPC1MAPTALDH1A1
Hydrochloric Acid SCHEMBL20529544 0.79 RAB9A (0.54) ABCB1RAB9ANPC1MAPTALDH1A1
SCHEMBL24140270 0.78 ABCB1 (0.37) ABCB1RAB9ANPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4171653-A2 TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES Regeneron Pharmaceuticals, Inc. (US) 2023-05-03 EP disclosed
US-20230069722-A1 TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES REGENERON PHARMACEUTICALS, INC. 2023-03-02 US disclosed
WO-2021262910-A2 TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES REGENERON PHARMACEUTICALS, INC. (US) 2021-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230069722-A1 TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES SDCBP, TEK, TEKT1 ABCB1 895/4885RAB9A 1892/4885NPC1 2301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.